These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 4061127)
1. Plasma exchange in the treatment of heterozygous familial hypercholesterolaemia. van de Wiel A; Kruiswijk T; de Gruijter J; Hart HC; Imhof JW Acta Med Scand; 1985; 218(2):233-9. PubMed ID: 4061127 [TBL] [Abstract][Full Text] [Related]
2. Effects of plasma exchange on serum cholesterol levels in heterozygous familial hypercholesterolemia. van de Wiel A; Kruiswijk T; Imhof JW; Hart HC; Holtkamp HC; Szakaly M Acta Med Scand; 1981; 210(6):461-5. PubMed ID: 7331893 [TBL] [Abstract][Full Text] [Related]
3. Plasma exchange in a patient with heterozygous familial hypercholesterolaemia resistant to drug therapy. Eriksson M; Lantz B; Berglund L; Angelin B Acta Med Scand; 1987; 221(3):317-20. PubMed ID: 3591471 [TBL] [Abstract][Full Text] [Related]
4. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia. Wierzbicki AS; Lumb PJ; Semra YK; Crook MA QJM; 1998 Apr; 91(4):291-4. PubMed ID: 9666952 [TBL] [Abstract][Full Text] [Related]
5. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis]. Schrecker O; Thies K; Schlierf G Internist (Berl); 1984 Sep; 25(9):574-6. PubMed ID: 6386739 [No Abstract] [Full Text] [Related]
6. Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue culture. Keller C; Hailer S; Demant T; Wolfram G; Zöllner N Atherosclerosis; 1985 Nov; 57(2-3):225-34. PubMed ID: 4084356 [TBL] [Abstract][Full Text] [Related]
7. Double-filtration plasmapheresis in heterozygous familial hypercholesterolemia: our experience over 25 treatments. Candrina R; Spandrio S; Di Stefano O; Scalvini T; Cotelli M; Tosoni M; Giustina G Beitr Infusionsther; 1988; 23():189-90. PubMed ID: 2484776 [No Abstract] [Full Text] [Related]
8. Sixteen years of plasma exchange in a homozygote for familial hypercholesterolaemia. Leren TP; Fagerhol MK; Leren P J Intern Med; 1993 Feb; 233(2):195-200. PubMed ID: 8433081 [TBL] [Abstract][Full Text] [Related]
9. Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine. Betteridge DJ; Bhatnager D; Bing RF; Durrington PN; Evans GR; Flax H; Jay RH; Lewis-Barned N; Mann J; Matthews DR BMJ; 1992 May; 304(6838):1335-8. PubMed ID: 1611329 [TBL] [Abstract][Full Text] [Related]
18. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia. Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541 [TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia. Mabuchi H; Koizumi J; Kajinami K Am J Cardiol; 1998 Aug; 82(4B):52J-55J. PubMed ID: 9737647 [TBL] [Abstract][Full Text] [Related]
20. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia. Jackson JM; Lee HA Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]